Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Bisoprolol
Drug ID BADD_D00277
Description Bisoprolol is a cardioselective β1-adrenergic blocking agent used to treat high blood pressure.[A180472,L7219] It is considered a potent drug with a long-half life that can be used once daily to reduce the need for multiple doses of antihypertensive drugs.[A180472] Bisoprolol is generally well tolerated, likely due to its β1-adrenergic receptor selectivity and is a useful alternative to non-selective β-blocker drugs in the treatment of hypertension such as [Carvedilol] and [Labetalol]. It may be used alone or in combination with other drugs to manage hypertension[L7219] and can be useful in patients with chronic obstructive pulmonary disease (COPD) due to its receptor selectivity.[A180562]
Indications and Usage For management of heart failure, angina pectoris, and mild to moderate hypertension and for secondary prevention of myocardial infarction (MI).
Marketing Status Prescription; Discontinued
ATC Code C07AB07
DrugBank ID DB00612
KEGG ID D02342
MeSH ID D017298
PubChem ID 2405
TTD Drug ID D0K3ZR
NDC Product Code Not Available
Synonyms Bisoprolol | Bisoprolol Fumarate (1:1) Salt, (+-)-Isomer | Bisoprolol Fumarate (2:1) Salt, (+-)-Isomer | Bisoprolol Hydrochloride | Hydrochloride, Bisoprolol | Bisoprolol Methanesulfonate Salt | Bisoprolol, (+-)-Isomer | Bisoprolol, Fumarate (1:1) Salt | Bisoprolol, Fumarate (2:1) Salt | CL-297939 | CL 297939 | CL297939 | Concor | EMD-33512 | EMD 33512 | EMD33512 | Bisoprolol Fumarate | Fumarate, Bisoprolol | Bisoprolol, (-)-Isomer
Chemical Information
Molecular Formula C18H31NO4
CAS Registry Number 66722-44-9
SMILES CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 2D6P10635T57392Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Eye pain06.08.03.002--
Eyelid oedema23.04.01.003; 10.01.05.001; 06.04.04.0040.001342%Not Available
Face oedema23.04.01.004; 10.01.05.002; 08.01.07.0030.001342%
Fatigue08.01.01.002--
Feeling abnormal08.01.09.0140.009392%Not Available
Feeling cold08.01.09.0080.001342%Not Available
Feeling hot08.01.09.0090.004696%Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Flushing24.03.01.002; 23.06.05.003; 08.01.03.025--
Fracture15.08.02.001; 12.04.02.001--
Gait disturbance17.02.05.016; 08.01.02.0020.008050%
Galactorrhoea21.05.02.002; 05.03.04.002--Not Available
Gallbladder disorder09.03.02.0010.001342%Not Available
Gamma-glutamyltransferase increased13.03.01.0110.006038%
Gastritis07.08.02.0010.001342%
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal pain07.01.05.005--
Generalised oedema08.01.07.004; 14.05.06.007--
Gestational diabetes18.02.04.001; 14.06.01.008; 05.06.01.0080.001342%Not Available
Gingival swelling07.05.04.0030.001342%Not Available
Glossitis07.14.01.0010.002013%Not Available
Glycosylated haemoglobin increased13.02.02.0050.001342%Not Available
Goitre14.11.01.008; 05.02.01.0010.001342%Not Available
Gout15.01.06.001; 14.09.01.001--Not Available
Haemangioma congenital16.02.01.004; 03.07.03.002; 24.03.06.0050.002013%Not Available
Haematemesis24.07.02.011; 07.12.02.0020.004696%Not Available
Haematochezia07.12.02.003; 24.07.02.0120.002013%Not Available
Haematoma24.07.01.0010.002683%
Haematuria24.07.01.047; 20.02.01.0060.005367%
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 20 Pages